TB and M/XDR-TB infection control in European TB reference centres: the Achilles' heel?

被引：44
|
作者：
Sotgiu, G. [2 ]
D'Ambrosio, L. [1 ]
Centis, R. [1 ]
Bothamley, G. [5 ]
Cirillo, D. M. [3 ]
De Lorenzo, S. [4 ]
Guenther, G. [6 ]
Kliiman, K. [8 ]
Muetterlein, R. [7 ]
Spinu, V. [9 ]
Villar, M. [10 ,11 ]
Zellweger, J. P. [12 ]
Sandgren, A. [13 ]
Huitric, E. [13 ]
Lange, C. [6 ]
Manissero, D. [13 ]
Migliori, G. B. [1 ]
机构：
[1] Fdn S Maugeri, Care & Res Inst, World Hlth Org Collaborating Ctr TB & Lung Dis, I-21049 Tradate, Italy
[2] Univ Sassari, Hyg & Prevent Med Inst, I-07100 Sassari, Italy
[3] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy
[4] Reference Hosp MDR & HIV TB, E Morelli Hosp, Sondalo, Italy
[5] Homerton Univ Hosp, London, England
[6] Res Ctr Borstel, Div Clin Infect Dis, Med Clin, Borstel, Germany
[7] Parsberg Hosp, Dept Med, Parsberg, Germany
[8] Univ Tartu, Dept Pulm Med, EE-50090 Tartu, Estonia
[9] Marius Nasta Inst Pulmonol, MDR TB Ctr, Bucharest, Romania
[10] Gen Directorate Hlth Lisbon, Amadora, Portugal
[11] Lung Dis Ctr Venda Nova, Amadora, Portugal
[12] Univ Lausanne, Dept Ambulatory Care & Community Med, TB Clin, Lausanne, Switzerland
[13] European Ctr Dis Prevent & Control, Sci Advice Unit, Stockholm, Sweden
来源：
EUROPEAN RESPIRATORY JOURNAL | 2011年 / 38卷 / 05期
关键词：
DRUG-RESISTANT TUBERCULOSIS; XDR-TB; MANAGEMENT;
D O I：
10.1183/09031936.00029311
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：1221 / 1223
页数：3
相关论文
共 50 条
  • [31] XDR-TB in South Africa: Revised definition
    Holtz, Timothy H.
    PLOS MEDICINE, 2007, 4 (04) : 770 - 770
  • [32] WHAT IS THE OPTIMUM TREATMENT OF MDR/XDR-TB?
    Huang, Y. W.
    RESPIROLOGY, 2016, 21 : 19 - 19
  • [33] Linezolid for XDR-TB - Final Study Outcomes
    Lee, Myungsun
    Cho, Sang Nae
    Barry, Clifton E., III
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03): : 290 - 291
  • [34] Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB
    Reimann, M.
    Schaub, D.
    Kalsdorf, B.
    Runge, C.
    Carballo, P. Sanchez
    Terhalle, E.
    Salzer, H. J. F.
    Lange, C.
    Heyckendorf, J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (01) : 93 - 98
  • [35] Is M/XDR-TB Treatment with Bedaquiline Beyond Six Months Safe?
    Skrahina, A.
    Gurbanova, E.
    Setkina, S.
    Hurevich, H.
    Altraja, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [36] Streptomycin Susceptibility and MDR-TB: Can We Refine the Definition of XDR-TB?
    Chang, Kwok Chiu
    Leung, Chi Chiu
    Tam, Cheuk Ming
    Yew, Wing Wai
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (02) : 278 - 278
  • [37] Prevalence of pre-XDR-TB, XDR-TB among MDR-TB Patients registered at Ojha Institute of Chest Diseases, Karachi
    Rao, Nisar
    Baig, Saifullah
    Hussain, Niaz
    Ahmed, Nadeem
    Rao, Danish
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [38] Transmission Dynamics of MDR-TB and XDR-TB in Areas of Varying HIV Prevalence
    Victor, T. C.
    Calver, A.
    Falmer, A.
    Strauss, O.
    Streicher, E.
    Louw, G.
    Johnson, R.
    Trollip, A.
    Jordaan, A.
    van Helden, P. D.
    Warren, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E45 - E46
  • [39] Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB
    Martins, M.
    Viveiros, M.
    Couto, I.
    Amaral, L.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (05) : 569 - 573
  • [40] Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation
    Caminero, J. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (08) : 869 - 877
12345